Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications; D001803:Blood Transfusion; D002177:Candidiasis / Q000150:complications; D003453:Cryptococcosis / Q000150:complications; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007501:Iron / Q000378:metabolism; D007938:Leukemia / Q000150:complications*; D007945:Leukemia, Lymphoid / Q000150:complications; D008223:Lymphoma / Q000150:complications*; D009089:Mucor / Q000472:pathogenicity; D009101:Multiple Myeloma / Q000150:complications; D009181:Mycoses / Q000150:complications* / Q000175:diagnosis / Q000517:prevention & control; D009503:Neutropenia / Q000150:complications; D012233:Rhizopus / Q000472:pathogenicity
D000305:Adrenal Cortex Hormones; D000666:Amphotericin B; D005437:Flucytosine; D007501:Iron